Some very good points havasu78. Thanks for sharing.

This one in particular I had not considered:

Quote:

---

1) Mexico protocol permits combining 25 Mexico patients with the 50 interim patients from the US phase 2/3 severe/critical trial

---

Regarding this comment:

Quote:

---

At any rate, I think the main point is just what you said: they picked 25 for Mexico cuz they knew the US results, perhaps even they knew the intirety of the US results yesterday when the finalized Mexico.

---

I'd would just like to say the 25 subject trial was discussed way back at the very beginning of the Mexico trail announcement. As such, I don't view it as a product of any recent event, such as CytoDyn's potential understanding of the US P3 S/C results.